Critical CDC Data Systems Go Dark, Blinding U.S. Health Officials

Nearly half of the public health surveillance databases run by the Centers for Disease Control and Prevention have stopped updating, according to an NBC News investigation. This breakdown leaves a significant gap in the nation’s ability to track vaccination drives and spot emerging outbreaks.

The analysis found that roughly 48 out of 100 CDC databases are no longer being regularly maintained. These are not minor reports; they are core systems that state and local health departments use to monitor flu, RSV, childhood immunizations, and COVID-19. The erosion of this infrastructure means officials are allocating resources and crafting policy without current, reliable information.

Experts point to a combination of factors: chronic budget pressures, internal reorganizations, and a loss of institutional knowledge as experienced staff depart. The pandemic strained the agency further, highlighting the need for robust data while simultaneously degrading the systems that provide it. Many databases rely on outdated technology that few current employees know how to operate.

The silence is most pronounced in vaccine tracking. Systems that once provided near real-time data on immunization rates across demographics and regions have gone dormant. This comes as measles and whooping cough resurge in parts of the country. The deterioration makes it harder to identify communities with low coverage before an outbreak begins.

The ripple effects are widespread. State health departments are scrambling to create their own tracking methods, leading to a fragmented national picture. Academic and pharmaceutical research dependent on CDC data has been disrupted. Efforts to modernize the systems, like the Data Modernization Initiative, have struggled to keep pace with the decay.

Under the Trump administration, which took office in 2025, the CDC faces intense political scrutiny and shifting priorities. Staff describe low morale and a sense that maintaining these essential but unglamorous data pipelines is not a priority. The situation casts doubt on U.S. preparedness for the next health crisis, suggesting the country may be even less equipped to track a novel pathogen than it was in 2020.